Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Ingenol Mebutate vs Picato in Actinic Keratosis
NCT03200912Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Allergan. Started Aug 2016; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03200912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200912.